Human C4.4A/LYPD3 Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human C4.4A/LYPD3 by Western Blot. Western blot shows lysates of SK‑BR‑3 human breast cancer cell line, MCF‑7 human breast cancer cell line, and RT-4 human bladder carcinoma cell line. PVDF membrane was probed with 0.5 µg/mL of Sheep Anti-Human C4.4A/LYPD3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF5428) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (HAF016). A specific band was detected for C4.4A/LYPD3 at approximately 75 kDa (as indicated). This experiment was conducted under reducing conditions and using Western Blot Buffer Group 1.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Background: C4.4A/LYPD3
LYPD3 (Ly6/PLAUR-domain containing protein 3; also MIG-C4 and GPI anchored metastasis-associated protein C4.4A) is an 85-95 kDa, variably glycosylated member of the Ly6 family of GPI anchored proteins. It is expressed on transitional epithelium, keratinocytes and monocytes, and binds laminin 1 and 5, plus Galectin-3. LYPD3 is believed to support cell migration. Mature human LYPD3 is a 296 amino acid (aa) GPI linked glycoprotein. It contains two UPAR domains (aa 33-126 and 140-222), and an ADAM cleavage site (aa 312-325). The molecule shows extensive N and O linked glycosylation. There is one potential isoform that shows a deletion of aa 129-180. Over aa 31-286, human LYPD3 shares 81% aa identity with mouse LYPD3.
Product Datasheets
Citation for Human C4.4A/LYPD3 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells
Authors: M Görtz, U Galli, T Longerich, M Zöller, U Erb, P Schemmer
Oncol. Rep., 2017-09-20;38(5):2697-2704.
Species: Human
Sample Types: Whole Cells
Applications: ICC
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human C4.4A/LYPD3 Antibody
There are currently no reviews for this product. Be the first to review Human C4.4A/LYPD3 Antibody and earn rewards!
Have you used Human C4.4A/LYPD3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image